Journal details
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
PERGAMON-ELSEVIER SCIENCE LTD · ISSN 0278-5846 · eISSN 1878-4216
SCIEScopusMEDLINEPubMedPMC
Overview
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. ISSN 0278-5846 · eISSN 1878-4216. published by PERGAMON-ELSEVIER SCIENCE LTD. England. Clinical Neurology · Neurosciences · Pharmacology & Pharmacy. impact factor 4.2 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 164 articles · 2025: 336 articles · 2024: 277 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY?
The impact factor recorded for PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY is 4.2 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY?
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY is listed in CAS Zone 2.
Which databases index PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY?
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.